Quick navigation menu :

  1. Go to the content
  2. Go to main section's menu
  3. Go to Search tool
  4. Go to Help menu
  5. Go to modules
  6. Go to the list of keyboard shortcuts

Help menu :

  1. Sanofi Worldwide |
     
  2. Our Websites |
     
  3. Global Business Webistes |
     
  4. Contact Us |
  5. Sitemap |
  6. Help
  1. Font size

    Reduce font size Increase font size  
 
 

Contact us

Sanofi House,
CTS No.117-B, L&T Business Park,
Saki Vihar Road, Powai,
Mumbai 400072

Tel no. (022) 28032000
Fax no.(022) 28032846 

For redressal of investor grievances, please write to

Registrar & Share Transfer Agent
Link Intime India Pvt. Ltd
C101, 247 Park, L B S Marg,
Vikhroli West, Mumbai 400083.
Email: rnt.helpdesk@linkintime.co.in
Tel.: (91 22) 49186270
Fax: (91 22) 49186060

Company Secretary, Compliance Officer & Nodal Officer
Mr. Girish Tekchandani

Sanofi India Limited
E-Mail ID: igrc.sil@sanofi.com
Tel.: (91-22) 28032000
Fax: (91-22) 28032846

Content :

Profile of Directors

Aditya Narayan

Chairman


Aditya Narayan joined the Board effective 30th April 2016.

Aditya Narayan brings with him a rich industry experience of over 40 years. He served the erstwhile ICI Limited, now known as Akzo Nobel India Limited, for about 30 years across diverse functions and businesses. He was its Managing Director from 1996-2003 and then its non-executive Chairman from 2003-2010. From 2005-2009, he was the President and CEO of BHP Billiton, India. Additionally, he has served as an Independent Director on the Boards of number of companies.

Rajaram Narayanan

Managing Director


Rajaram Narayanan joined the Board on 21st October 2015. He was appointed as the Managing Director of the Company with effect from 1st January 2018.

Rajaram Narayanan joined Sanofi as Country Head and General Manager - Pharmaceutical Operations, India in 2014. At Sanofi, he brought with him a rich experience of 19 years with Unilever in India and South East Asia. At Unilever, he held a variety of sales and marketing roles, where he built and managed some of the Company’s most iconic brands. More recently, Rajaram worked for over 2 years at one of India’s largest telecom companies – Bharti Airtel, as Chief Marketing Officer and CEO (Data & Digital group) successively.

Rangaswamy R. Iyer

Independent Director


Rangaswamy R. Iyer joined the Board on 30th October 2013.

Rangaswamy Iyer is currently an Advisor / Consultant to various companies in the Pharma Industry in the areas of Mergers, Acquisitions, Business Strategy and Business Development. He is also an Advisor to Global Pharma Associations in the areas of Intellectual Property Rights / Regulatory matters, and to India Health Progress. He was the Managing Director of Wyeth Limited, subsidiary of Wyeth USA for 10 years till end Oct 2009.He joined Cyanamid in 1980, transitioned to Wyeth in 1998 and rose to become its Managing Director in the year 2000. He has also been President of Organisation of Pharmaceutical Producers of India (OPPI) from 2007 to 2009, President of American Chamber of Commerce, Mumbai Chapter, Managing Committee Member of Bombay Chamber of Commerce for four years and of Indian Merchants Chamber for one year.

Usha Thorat

Independent Director


Usha Thorat joined the Board on 30th April 2017.

Usha Thorat joined the Reserve Bank of India (RBI) in 1972. She became its Deputy Governor in 2005 and remained in this position till 2010. After stepping down from RBI, Usha Thorat was entrusted by the RBI to set up the Centre for Advanced Financial Research and Learning (CAFRAL) in banking and finance. She held charge as Director of CAFRAL from 2011 to 2014. She is active with a number of non-Governmental organizations including the Indian Cancer Society as trustee and Chairperson of the Governing and Advisory Council of the Cancer Cure Fund. She is a member of the Board of Governors of the Foundation for Ecological Security that works on issues of sustainability and equitable development, and is a Trustee of the Impact India Foundation that works in the health space. She is also Vice President of the Bombay Natural History Society.

Shailesh Ayyangar

Non-Executive Director


Shailesh Ayyangar was the Managing Director of the Company upto 31st December 2017 and currently Non-Executive Director of the Company with effect from 1st January 2018.

Prior to joining Sanofi, Shailesh held senior positions for 14 years in SmithKline Beecham Pharmaceuticals and GlaxoSmithKline (GSK), in India and in Great Britain. He began his career as a practicing veterinarian in the rural areas of Gujarat where he was employed by the National Dairy Development Board. With his wide-ranging experience of over three decades in the industry, Dr. Ayyangar leads the OPPI (Organization of Pharmaceutical Producers’ of India) - an industry body representing research based pharmaceutical companies of India. Since 2013, he has been unanimously elected as the President of OPPI.

Cyril Grandchamp-Desraux

Non-Executive Director


Cyril Grandchamp-Desraux joined the Board on 27th February 2017.

Cyril Grandchamp-Desraux joined Sanofi in 2002, after starting his career as sell-side financial analyst in Natixis. He held successive positions at Sanofi Headquarter in Paris as Business Control & Support Manager for Global Commercial Operations, Strategic Planning for APAC Region, Attaché to the SVP of APAC Region, and Chief of Staffs of the President Global Pharmaceutical Operations until he became General Manager Finland & Head of Diabetes Division for Nordic & Baltic countries in 2010. He was then appointed as Head of Indochina and General Manager in Vietnam in 2012. In April 2015, he was promoted to ASEAN Zone Head Rx and Singapore Country Chair, and subsequently, in Jan 2017, he was appointed as Head of Asia Business for Sanofi.

Thomas Rouckout

Non-Executive Director


Thomas Rouckout joined the Board on 27th February 2017.

Thomas Rouckout started his career in the year 2002 with the Ministry of Economy, Finance and Industry, in Paris as Portfolio Manager supporting French public companies in the implementation of their strategic decisions such as major capital expenditures, mergers and acquisitions. He also helped preparing and implementing the privatization process of public companies on behalf of the French Government. From year 2006 to 2012, he joined Alstom Group first as Group Management Controller in Corporate, then as CFO for the Alstom Power Gas turbines Operations and Maintenance business in Zurich, Switzerland, then as Vice-President Finance, Operations Controlling for the Grid sector. He joined Sanofi in 2012 as Group Controller and is currently, the Head of Finance for Pharma Solids in Industrial Affairs.

Charles Billard

Whole Time Director and Chief Financial Officer


Charles Billard was appointed as the Chief Financial Officer in July 2018.

Charles joined Sanofi in 2014 as the Head of Strategy and Business Development for Global Consumer Healthcare Division. Since 2016, Charles has been heading Financial Planning & Performance department for the General & Emerging Markets Global Business Unit (GBU). Prior to Sanofi, he spent 9 years in Strategy Consulting with The Boston Consulting Group.

Charles has a Master’s degree from Ecole Centrale Paris engineering school.

Ashwani Sood

Whole Time Director


Ashwani Sood joined the Board on 21st October 2015.

Ashwani Sood was appointed Senior Director, Industrial Affairs, South Asia, in April 2015. He joined the Company in 1988 as Officer–Production in the Mumbai factory. During his long sting with Sanofi, Ashwani worked at different positions, and rose to the level of Senior Director - Ankleshwar site prior to being appointed at the current position. Before joining Sanofi, Ashwani worked with E Merck and Searle India Limited.

Details of Board Committees

Audit Committee

  • Mrs. Usha Thorat, Chairperson
  • Mr. Rangaswamy R. Iyer
  • Dr. Shailesh Ayyangar

Nomination and Remuneration Committee

  • Mrs. Usha Thorat, Chairperson
  • Mr. Rangaswamy R. Iyer
  • Mr. Cyril Grandchamp-Desraux

Stakeholders Relationship Committee

  • Mr. Rangaswamy R Iyer – Chairman
  • Mr. Rajaram Narayanan
  • Mr. Charles Billard

Corporate Social Responsibility Committee

  • Mr. Rangswamy R. Iyer, Chairman
  • Ms. Usha Thorat
  • Dr. Shailesh Ayyangar
  • Mr. Rajaram Narayanan

Updated August 22, 2018